Online citations, reference lists, and bibliographies.
← Back to Search

Inorganic Matrices: An Answer To Low Drug Solubility Problem

L. Perioli, C. Pagano
Published 2012 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Introduction: Many active pharmaceutical ingredients (APIs), in development and already on the market, show a limited and variable bioavailability mainly associated to inadequate biopharmaceutical properties such as aqueous solubility and dissolution rate. The latter is the main factor responsible for the limited, and sometimes inadequate, efficacy of many orally administered drugs, belonging to class II and IV of the Biopharmaceutics Classification System (BCS). Moreover, because of their low solubility, such drugs require high doses to be administered in order to obtain their pharmacological effect, increasing the side effect incidence. Areas covered: The present review reports the most common technological approaches intended to improve solubility and dissolution rate of BCS class II and IV drugs such as nanocrystals, solid dispersions, cyclodextrins and solid lipid nanoparticles. Particular attention will be focused on the use of inorganic matrices (lamellar anionic clays and mesoporous materials) as host for the delivery of poor soluble APIs (guest). Expert opinion: The employment of inorganic matrices for the realization of host–guest composites is a suitable strategy for the biopharmaceutical properties enhancement. This objective can be achieved without any modification of API chemical structure.
This paper references
Layered double hydroxydes and their intercalation compounds in photochemistry and medicinal chemistry
U Costantino (2001)
10.1016/J.IJPHARM.2005.01.040
Intercalation of the radical scavenger ferulic acid in hydrotalcite-like anionic clays.
C. Rossi (2005)
the correlation of in vitro drug product Inorganic matrices: an answer to low drug solubility problem Expert Opin
GL Amidon (2012)
10.1016/J.MICROMESO.2007.02.005
Hydrotalcite-like compounds: Versatile layered hosts of molecular anions with biological activity
U. Costantino (2008)
10.1023/A:1016212804288
A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
G. Amidon (2004)
10.1016/j.ejps.2012.02.004
Use of SBA-15 for furosemide oral delivery enhancement.
V. Ambrogi (2012)
10.1016/J.BIOMATERIALS.2003.09.083
Layered double hydroxide as an efficient drug reservoir for folate derivatives.
J. Choy (2004)
10.1016/J.MICROMESO.2004.03.027
Molecular sieves as host materials for supramolecular organization
D. Brühwiler (2004)
10.2165/00003088-199936030-00004
Drug, Meal and Formulation Interactions Influencing Drug Absorption After Oral Administration
D. Fleisher (1999)
10.1016/j.ijpharm.2010.09.039
Inorganic-polymer nanohybrid carrier for delivery of a poorly-soluble drug, ursodeoxycholic acid.
G. Choi (2010)
10.1016/J.CLAY.2011.06.006
Preformulation studies on host–guest composites for oral administration of BCS class IV drugs: HTlc and furosemide
L. Perioli (2011)
10.1016/J.JHAZMAT.2007.01.006
Arsenic removal from water/wastewater using adsorbents--A critical review.
D. Mohan (2007)
10.1007/s11094-009-0265-4
The role of excipients in determining the pharmaceutical and therapeutic properties of medicinal agents (Review)
G. Aleeva (2009)
Physicochemical hydrodynamics. Prentice-Hall; Englewood Cliffs, N.J
VG Levich (1962)
10.1038/nrd2197
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
C. H. Porter (2007)
10.1002/jps.21650
Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?
J. Brouwers (2009)
10.1007/BF02830560
In vivo and in vitro characterization of novel microparticulates based on hyaluronan and chitosan hydroglutamate
St Lim (2008)
10.1021/LA981672U
Anion Exchange of Methyl Orange into Zn−Al Synthetic Hydrotalcite and Photophysical Characterization of the Intercalates Obtained
U. Costantino (1999)
10.1016/S0378-5173(01)00629-9
Intercalation compounds of hydrotalcite-like anionic clays with antiinflammatory agents--I. Intercalation and in vitro release of ibuprofen.
V. Ambrogi (2001)
10.1016/J.SSI.2004.04.035
Synthesis and characterization of hydrotalcite-ATP intercalates
H. Tamura (2004)
An important study in which the suitability of hydrotalcite for the delivery of poor soluble drugs has been evaluated for the first time
Predicting DMPK of NMEs: what do we need in terms of science and tools? New England drug metabolism discussion group: Gerald Miwa Retirement Symposium
L Z Benet (2007)
10.1016/J.CLAY.2010.06.028
Intercalation and release of antiinflammatory drug diclofenac into nanosized ZnAl hydrotalcite-like compound
L. Perioli (2011)
10.1016/S1359-6446(04)03351-3
Formulation strategies for absorption windows.
S. Davis (2005)
10.1016/j.ejpb.2009.06.007
Effect of gliclazide immobilization into layered double hydroxide on drug release.
V. Ambrogi (2009)
10.1016/J.MICROMESO.2007.02.021
Sunscreen immobilization on ZnAl-hydrotalcite for new cosmetic formulations.
L. Perioli (2008)
Solid-state supramolecular chemistry : two-and three-dimensional inorganic networks
G. Alberti (1996)
10.1016/j.ejps.2010.03.003
Wettability and surface chemistry of crystalline and amorphous forms of a poorly water soluble drug.
V. Puri (2010)
Nonionic triblock and star diblock copolymer and L
D Zhao (2012)
10.1517/17425247.2.3.419
Strategies to improve oral drug bioavailability
I. Gómez-Orellana (2005)
10.1002/JPS.10411
Effect of hydrotalcite-like compounds on the aqueous solubility of some poorly water-soluble drugs.
V. Ambrogi (2003)
10.1016/J.ADDR.2007.05.006
Oral lipid-based formulations.
D. Hauss (2007)
10.1016/J.CLAY.2010.12.019
Effects of hydrotalcite-like nanostructured compounds on biopharmaceutical properties and release of BCS class II drugs: The case of flurbiprofen
L. Perioli (2011)
10.1016/S0169-409X(00)00130-7
Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract.
D. Hörter (2001)
10.1016/J.MICROMESO.2008.07.002
Ordered mesoporous materials for drug delivery
S. Wang (2009)
10.1126/SCIENCE.279.5350.548
Triblock copolymer syntheses of mesoporous silica with periodic 50 to 300 angstrom pores
Y Zhao (1998)
10.1016/J.MICROMESO.2007.12.003
Role of mesoporous silicates on carbamazepine dissolution rate enhancement
V. Ambrogi (2008)
Interesting study about hydrotalcite ability to stabilize the host molecules from physical modifications
10.1016/J.MICROMESO.2008.02.014
Eudragit® and hydrotalcite-like anionic clay composite system for diclofenac colonic delivery
V. Ambrogi (2008)
10.1002/JPS.20054
Mg,Al layered double hydroxides with intercalated indomethacin: synthesis, characterization, and pharmacological study.
M. del Arco (2004)
10.1180/claymin.2008.043.2.08
Solubility and release of fenamates intercalated in layered double hydroxides
M. del Arco (2008)
10.1016/J.DRUDIS.2006.09.002
Solubility: it's not just for physical chemists.
Shobha N. Bhattachar (2006)
10.1016/J.CLAY.2006.06.010
Layered double hydroxides and human health: An overview
C. D. Hoyo (2007)
10.1208/pt0803054
Mucoadhesive bilayered tablets for buccal sustained release of flurbiprofen
L. Perioli (2008)
10.1002/jps.21638
Ordered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugs.
Michiel van Speybroeck (2009)
10.1002/jps.21733
Drug mechanochemical activation.
I. Colombo (2009)
10.1016/J.CES.2011.12.036
Theoretical and experimental analysis of drug release from an ensemble of polymeric particles containing amorphous and nano-crystalline drug
N. Coceani (2012)
10.1016/J.EJPB.2006.10.006
Use of calcined Mg-Al-hydrotalcite to enhance the stability of celecoxib in the amorphous form.
V. Ambrogi (2007)
Recommendations for the use of anti-inflammatory drugs and indications for gastrointestinal protection in emergency departments
Emili (2010)
10.1039/B603723B
Hydrothermal stability of SBA-15 and related ordered mesoporous silicas with plugged pores
E. B. Celer (2006)
Predicting DMPK of NMEs: what do we need in terms of science and tools? New England drug metabolism discussion group
LZ Benet (2007)
10.1007/s11095-006-9062-x
Amorphization of Indomethacin by Co-Grinding with Neusilin US2: Amorphization Kinetics, Physical Stability and Mechanism
Deepak Bahl (2006)
10.1016/J.IJPHARM.2006.07.011
A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system.
A. Dokoumetzidis (2006)
10.1016/J.JCAT.2004.10.006
Methane autothermal reforming with and without ethane over mono- and bimetal catalysts prepared from hydrotalcite precursors
Katsutoshi Nagaoka (2005)
10.1021/CG200492W
Solubility Advantage of Amorphous Drugs and Pharmaceutical Cocrystals
N. J. Babu (2011)
A deep overview of the versatility of hydrotalcite matrices
10.1021/JA974025I
Nonionic Triblock and Star Diblock Copolymer and Oligomeric Surfactant Syntheses of Highly Ordered, Hydrothermally Stable, Mesoporous Silica Structures
D. Zhao (1998)
10.1351/pac200678091771
Layered double hydroxide nanomaterials as potential cellular drug delivery agents
Z. P. Xu (2006)
10.1002/9783527626854.CH13
Ordered Mesoporous Materials
D. Zhao (2009)
10.1016/J.MICROMESO.2011.07.007
MCM-41 for furosemide dissolution improvement
V. Ambrogi (2012)
10.1007/BF02830624
Intercalation compounds of hydrotalcite-like anionic clays with anti-inflammatory agents, II: Uptake of diclofenac for a controlled release formulation
V. Ambrogi (2008)
10.1016/J.JPCS.2006.01.029
Use of anionic clays for photoprotection and sunscreen photostability: Hydrotalcites and phenylbenzimidazole sulfonic acid
L. Perioli (2006)
10.1517/17425240903304024
Drug delivery from ordered mesoporous matrices
M. Manzano (2009)
10.1016/J.CLAY.2009.10.016
Clay and non-clay minerals in the pharmaceutical and cosmetic industries Part II. Active ingredients
M. Carretero (2010)
10.1016/0378-5173(95)00033-F
The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs
M. Mosharraf (1995)
10.2133/DMPK.22.225
Solubility and dissolution profile assessment in drug discovery.
Kiyohiko Sugano (2007)
10.1016/S0927-7757(01)00637-9
Freezing behavior in porous glasses and MCM-41
M. Śliwińska-Bartkowiak (2001)
10.1021/JA00053A020
A new family of mesoporous molecular sieves prepared with liquid crystal templates
J. S. Beck (1992)
10.1002/BDD.1803
Mechanistic analysis of solute transport in an in vitro physiological two‐phase dissolution apparatus
P. Langguth (2012)
The insoluble solved
SB Ruddy (2011)
Inorganic matrices: an answer to low drug solubility problem
(2012)
10.1016/J.COLSURFA.2004.04.010
N2 sorption scanning behavior of SBA-15 porous substrates
J. Esparza (2004)
10.1080/10717540601098823
Evaluation of Mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 Materials as API Carriers for Oral Drug Delivery
T. Heikkilä (2007)
10.1016/J.EJPS.2007.07.005
Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.
V. Ambrogi (2007)
10.1016/J.CLAY.2011.10.006
Selective internalization of ZnAl-HTlc nanoparticles in normal and tumor cells. A study of their potential use in cellular delivery
Tamara Posati (2012)
10.1517/17425255.2.4.591
The road map to oral bioavailability: an industrial perspective
V. H. Thomas (2006)
10.1016/J.EJPS.2004.03.004
Food effects on tablet disintegration.
B. Abrahamsson (2004)
10.1002/jps.21903
Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.
S. Murdande (2010)
10.1016/J.MICROMESO.2009.03.046
Verified syntheses of mesoporous materials
V. Meynen (2009)
A landmark study of the important effect of protection from UV rays that hydrotalcite exert on drug molecules stored in their galleries
10.1016/J.CLAY.2010.11.027
Dissolution of nano-size Mg–Al–Cl hydrotalcite in aqueous media
M. Jobbágy (2011)
10.1038/268298a0
Physicochemical hydrodynamics
S. Bruckenstein (1977)
10.1023/B:PHAM.0000008037.57884.11
Quantitative Biopharmaceutics Classification System: The Central Role of Dose/Solubility Ratio
E. Rinaki (2004)
10.2147/IJN.S595
Nanocrystal technology, drug delivery and clinical applications
Jens-Uwe A. H. Junghanns (2008)
10.2174/1389200043335423
Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research.
M. Varma (2004)
10.1002/POLB.21106
New nanohybrids of poly(ε‐caprolactone) and a modified Mg/Al hydrotalcite: Mechanical and thermal properties
Rachele Pucciariello (2007)
10.1346/CCMN.1983.0310409
Anion-Exchange Properties of Hydrotalcite-Like Compounds
Shigeo Miyata (1983)
Drug-like properties: concept, structure design and methods
EH Kerns (2008)
10.1016/j.jcis.2012.02.034
Synthesis of colloidal dispersions of NiAl, ZnAl, NiCr, ZnCr, NiFe, and MgFe hydrotalcite-like nanoparticles.
F. Bellezza (2012)
10.1016/J.EJPB.2004.03.001
Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.
Marc Lindenberg (2004)
10.1016/J.CLAY.2006.06.015
Use of clays as drug delivery systems: Possibilities and limitations
C. Aguzzi (2007)
10.1016/J.EJPB.2005.08.001
Anionic clays for sunscreen agent safe use: photoprotection, photostability and prevention of their skin penetration.
L. Perioli (2006)
10.1021/la802692z
Is there any microporosity in ordered mesoporous silicas?
A. Silvestre-Alberto (2009)
10.1016/S1056-8719(00)00107-6
Drug-like properties and the causes of poor solubility and poor permeability.
C. Lipinski (2000)
10.1016/j.ijpharm.2010.06.016
Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
Eunbi Cho (2010)
Wettability and surface chemistry of oligomeric surfactant syntheses of highly ordered, hydrotermally stable, mesoporous silica structures
V Puri (1998)
An important and deep analysis of the influence that drug properties exert in conditioning both solubility and permeability (absorption)
10.1002/jps.22030
Biowaiver monographs for immediate release solid oral dosage forms: furosemide.
G. Granero (2010)
10.1016/B978-012369520-8.50008-5
Chapter 7 – Solubility
E. Kerns (2008)
10.1038/359710A0
Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism
C. Kresge (1992)
10.1016/J.ADDR.2003.10.008
Drug polymorphism and dosage form design: a practical perspective.
Dharmendra Singhal (2004)
10.1021/mp100149j
Physiological parameters for oral delivery and in vitro testing.
D. Mudie (2010)
Solid Dispersions as Strategy to Improve Oral Bioavailability of Poor Water Soluble Drugs
Wagh Vinod Tukaram (2013)
An important overview showing the importance in the delivery of poor soluble drug in a non-crystalline form
10.1016/j.drudis.2010.08.007
Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability.
K. Kohli (2010)
10.1023/A:1011984216775
Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms
J. Dressman (2004)
10.1016/S0169-409X(96)00487-5
Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract.
D. Hörter (1997)
10.1016/J.CLAY.2006.07.007
Clay minerals and layered double hydroxides for novel biological applications
Jin-Ho Choy (2007)
10.1016/J.COLSURFA.2009.09.012
Rheological behavior of aqueous suspensions containing cationic starch and aluminum magnesium hydrotalcite-like compound in the presence of different electrolytes
Y. Li (2009)
10.1351/pac198557040603
Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity (Recommendations 1984)
K. S. Sing (1985)
Dissolution testing as prognostic tool for oral drug absorption: immediate release dosage
JB Dressman (1998)
10.1016/J.IJANTIMICAG.2006.11.019
Nanohybrids for controlled antibiotic release in topical applications.
L. Tammaro (2007)
10.1016/J.CLAY.2006.04.011
Intercalation of mefenamic and meclofenamic acid anions in hydrotalcite-like matrixes
M. Arco (2007)
10.1016/j.ijpharm.2012.02.041
Aminoalkyl methacrylate copolymers for improving the solubility of tacrolimus. I: Evaluation of solid dispersion formulations.
T. Yoshida (2012)
10.1016/j.ejps.2011.10.016
Study on formulation variables of methotrexate loaded mesoporous MCM-41 nanoparticles for dissolution enhancement.
Nasir Vadia (2012)
10.1016/J.IJPHARM.2006.02.045
Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals.
R. Mueller (2006)



This paper is referenced by
10.1007/S10904-018-0998-1
Mefenamic Acid-Layered Zinc Hydroxide Nanohybrids: A New Platform to Elaborate Drug Delivery Systems
H. Nabipour (2018)
10.1002/PEN.24877
Thermo‐mechanical and adhesive properties of polymeric films based on ZnAl‐hydrotalcite composites for active wound dressings
L. Perioli (2019)
10.3390/COSMETICS6020035
Development and Characterization of New Topical Hydrogels Based on Alpha Lipoic Acid—Hydrotalcite Hybrids
C. Pagano (2019)
10.1016/J.APSUSC.2017.04.187
Structural and electronic analysis of Li/Al layered double hydroxides and their adsorption for CO 2
Xinjuan Hou (2017)
10.2174/1381612826666191226112249
New Technological Approach For Glycyrrethic Acid Oral And Topical Administration.
C. Pagano (2019)
10.1007/s00396-017-4122-9
Design of nucleic acid-layered double hydroxide nanohybrids
Mónika Ádok-Sipiczki (2017)
10.1039/C4RA16957C
Hierarchical coated metal hydroxide nanoconstructs as potential controlled release carriers of photosensitizer for skin melanoma
R. K. Kankala (2015)
10.4028/www.scientific.net/AMR.787.177
Disk-Shaped Colloids: The Synthesis and Applications of ZrP Crystals
Zhengdong Cheng (2013)
10.1080/10717544.2017.1279238
pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms
L. Liu (2017)
10.1016/j.msec.2015.10.039
Mesoporous silica sub-micron spheres as drug dissolution enhancers: Influence of drug and matrix chemistry on functionality and stability.
L. Brigo (2016)
10.1039/C5RA26072H
Aggregation of layered double hydroxide nanoparticles in the presence of heparin: towards highly stable delivery systems
M. Pavlovi'c (2016)
10.1111/ijfs.13544
Optimisation of phenol extraction from wine using layered double hydroxides and technological evaluation of the bioactive‐rich powder
C. Pagano (2017)
10.1039/c3cp51235e
Structural characterization and thermal and chemical stability of bioactive molecule-hydrotalcite (LDH) nanocomposites.
E. Conterosito (2013)
10.1016/B978-0-12-804017-1.00002-9
Polymeric Microparticles and Inorganic Micro/Nanoparticulate Drug Carriers: An Overview and Pharmaceutical Application
D. Krajišnik (2017)
10.1002/chem.201500450
Structural Characterisation of Complex Layered Double Hydroxides and TGA-GC-MS Study on Thermal Response and Carbonate Contamination in Nitrate- and Organic-Exchanged Hydrotalcites.
E. Conterosito (2015)
10.1517/14656566.2014.879572
Perspective on the use of perampanel and intravenous carbamazepine for generalized seizures
V. Franco (2014)
10.1016/J.CLAY.2017.10.030
Effects of different milling techniques on the layered double hydroxides final properties
C. Pagano (2018)
10.1016/J.CLAY.2013.12.002
Intercalation of drugs in layered double hydroxides and their controlled release: A review
V. Rives (2014)
10.1007/s11356-017-9875-7
A bionanohybrid ZnAl-NADS ecological pesticide as a treatment for soft rot disease in potato (Solanum tuberosum L.)
Erika Elizabeth Morales-Irigoyen (2017)
10.1016/j.jcis.2015.07.044
Multi-laminated metal hydroxide nanocontainers for oral-specific delivery for bioavailability improvement and treatment of inflammatory paw edema in mice.
R. K. Kankala (2015)
10.1016/j.biopha.2020.110140
MgAl monolayer hydrotalcite increases the hypoglycemic effect of berberine by enhancing its oral bioavailability.
Aiting Wang (2020)
10.1016/j.ijpharm.2016.04.048
Preparation and optimization of a drug delivery system based on berberine chloride-immobilized MgAl hydrotalcite.
M. A. Djebbi (2016)
Semantic Scholar Logo Some data provided by SemanticScholar